/Boston%20Scientific%20Corp_%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
With a market cap of $156.3 billion, Boston Scientific Corporation (BSX) is a leading global developer, manufacturer, and marketer of medical devices. The company operates across key segments, including Cardiovascular, Rhythm & Neuro, and MedSurg, offering innovative solutions for heart disease, chronic pain, gastrointestinal, urological, and neurological conditions.
Companies valued at more than $10 billion are generally considered “large-cap” stocks, and Boston Scientific fits this criterion perfectly. With a diverse portfolio of internally developed and acquired technologies, Boston Scientific leverages both organic innovation and strategic acquisitions to drive growth worldwide.